Literature DB >> 18075651

Metallo-nucleosides: synthesis and biological evaluation of hexacarbonyl dicobalt 5-alkynyl-2'-deoxyuridines.

Craig D Sergeant1, Ingo Ott, Adam Sniady, Srinivasarao Meneni, Ronald Gust, Arnold L Rheingold, Roman Dembinski.   

Abstract

Reactions of 5-alkynyl-2'-deoxyuridines with dicobalt octacarbonyl Co2(CO)8 in THF at room temperature gave hexacarbonyl dicobalt nucleoside complexes (77-93%). The metallo-nucleosides were characterized, including an X-ray structure of a 1-cyclohexanol derivative. In crystalline form, the Co-Co bond is perpendicular to the plane of the uracil base, which is found in the anti position. The level of growth inhibition of MCF-7 and MDA-MB-231 human breast cancer cell lines was examined and compared to results obtained with the alkynyl nucleoside precursors. The cobalt compounds displayed good antiproliferative activities with IC50 values in the range of 5-50 microM. Interestingly, the coordination of the dicobalt carbonyl moiety to 5-alkynyl-2'-deoxyuridines led to a significant increase in the cytotoxic potency for alkyl/aryl substituents at the non-nucleoside side of the alkyne, but in the case of hydrogen (terminal alkyne) or a silyl group, a decrease of the cytotoxic effect was observed. As demonstrated using examples for an active and a low active target compound, the cytotoxicity was significantly influenced by the uptake into the tumor cells and the biodistribution into the nuclei.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075651     DOI: 10.1039/b713371e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  6 in total

1.  Synthesis and EPR studies of 2'-deoxyuridines with alkynyl, rodlike linkages.

Authors:  Adam Sniady; Michael D Sevilla; Srinivasarao Meneni; Tadeusz Lis; Slawomir Szafert; Deepthi Khanduri; John M Finke; Roman Dembinski
Journal:  Chemistry       Date:  2009-08-03       Impact factor: 5.236

Review 2.  Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.

Authors:  Sabine H van Rijt; Peter J Sadler
Journal:  Drug Discov Today       Date:  2009-09-24       Impact factor: 7.851

Review 3.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

4.  Organometallic Nucleosides: Synthesis and Biological Evaluation of Substituted Dicobalt Hexacarbonyl 2'-Deoxy-5-oxopropynyluridines.

Authors:  Renata Kaczmarek; Dariusz Korczyński; Karolina Królewska-Golińska; Kraig A Wheeler; Ferman A Chavez; Agnieszka Mikus; Roman Dembinski
Journal:  ChemistryOpen       Date:  2018-01-18       Impact factor: 2.911

5.  Extension of furopyrimidine nucleosides with 5-alkynyl substituent: Synthesis, high fluorescence, and antiviral effect in the absence of free ribose hydroxyl groups.

Authors:  Renata Kaczmarek; Dylan J Twardy; Trevor L Olson; Dariusz Korczyński; Graciela Andrei; Robert Snoeck; Rafał Dolot; Kraig A Wheeler; Roman Dembinski
Journal:  Eur J Med Chem       Date:  2020-09-28       Impact factor: 6.514

6.  Extension of the 5-alkynyluridine side chain via C-C-bond formation in modified organometallic nucleosides using the Nicholas reaction.

Authors:  Renata Kaczmarek; Dariusz Korczyński; James R Green; Roman Dembinski
Journal:  Beilstein J Org Chem       Date:  2020-01-02       Impact factor: 2.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.